ARCHIVES

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Guest Editorial – Power Shifts to Communities

January 9, 1976

In Brief: Upton Still Pondering Location Of Centers, Other Program; Moves Could Involve DCCR

April 27, 1979

HEW Ruling Limits Distribution Of Chemicals From Repository To Contractors, Government

May 7, 1976

Alimta Granted Approval As NSCLC Continuation Therapy

November 25, 2011

Clinical Oncology Grant Funding: The History Of a Controversy

July 23, 1993

In Brief: President Asks $700 Million for NCI In 1977; Appropriation Delay Halts New Research Funds

January 2, 1976